KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 138 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $220,563 | -59.5% | 56,700 | -64.6% | 0.00% | -70.0% |
| Q4 2022 | $545,044 | -85.2% | 160,307 | -76.2% | 0.01% | -85.7% |
| Q3 2022 | $3,678,000 | -53.3% | 673,672 | -61.4% | 0.07% | -67.7% |
| Q2 2022 | $7,872,000 | +1186.3% | 1,745,415 | +2000.9% | 0.22% | +1256.2% |
| Q1 2022 | $612,000 | +587.6% | 83,078 | +497.6% | 0.02% | +433.3% |
| Q4 2021 | $89,000 | -84.1% | 13,903 | -52.3% | 0.00% | -97.6% |
| Q1 2020 | $560,000 | -60.5% | 29,140 | -60.6% | 0.12% | +34.8% |
| Q4 2019 | $1,418,000 | – | 73,946 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |